APA (7th ed.) Citation

Akkerman-Nijland, A. M., Hagedoorn, P., Rottier, B. L., Grasmeijer, F., Frijlink, H. W., van Luin, M., . . . Koppelman, G. H. (2025). Tolerability and Pharmacokinetic Evaluation of Inhaled Dry Powder Tobramycin in Children with Cystic Fibrosis. Pharmaceutics, 17(3), 347. https://doi.org/10.3390/pharmaceutics17030347

Chicago Style (17th ed.) Citation

Akkerman-Nijland, Anne M., et al. "Tolerability and Pharmacokinetic Evaluation of Inhaled Dry Powder Tobramycin in Children with Cystic Fibrosis." Pharmaceutics 17, no. 3 (2025): 347. https://doi.org/10.3390/pharmaceutics17030347.

MLA (9th ed.) Citation

Akkerman-Nijland, Anne M., et al. "Tolerability and Pharmacokinetic Evaluation of Inhaled Dry Powder Tobramycin in Children with Cystic Fibrosis." Pharmaceutics, vol. 17, no. 3, 2025, p. 347, https://doi.org/10.3390/pharmaceutics17030347.